Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of cash, cash equivalents, and restricted cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported within the Unaudited Condensed Consolidated Balance Sheets to “Cash, cash equivalents, and restricted cash at end of period” as reported within the Unaudited Condensed Consolidated Statements of Cash Flows:


In thousands	March 31, 2022		December 31, 2021
Cash and cash equivalents	$	517	$	3,671

Restricted cash for future asset retirement obligations	46,695		46,673
Total cash, cash equivalents, and restricted cash shown in the Unaudited Condensed Consolidated Statements of Cash Flows	$	47,212	$	50,344

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following outstanding securities could potentially dilute earnings per share in the future, but were excluded from the computation of diluted net income (loss) per share for the three months ended March 31, 2022 and 2021, as their effect would have been antidilutive, as of the respective dates:


	March 31,
In thousands	2022	2021
Restricted stock, restricted stock units and performance stock units	1,005	1,276

Warrants	5,162	5,520